Evofem contracts second manufacturer for Phexxi contraceptive gel

Bitget2026/09/23 20:07

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Evofem Biosciences contracted a second pharmaceutical manufacturer to produce its PHEXX prescription contraceptive vaginal gel, expanding capacity to support US and international growth.
The added source is expected to improve manufacturing flexibility, strengthen supply resilience, reduce costs, and improve product economics, subject to regulatory clearance.
Evofem expects to file a supplemental new drug application with the FDA in mid-2027 for PHEXX made at the additional facility.
Commercial sales from the second supply are planned to start following FDA approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evofem Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260923178575) on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Evofem contracts second manufacturer for Phexxi contraceptive gel

You may also like

Crypto prices